Nylidrin hydrochloride is a vasodilating β‑adrenergic agonist formerly used to treat peripheral vascular disorders and certain organic mental symptoms in elderly patients. It improves blood flow to extremities and potentially the brain, with some evidence suggesting benefits for age-related cognitive impairment. However, due to insufficient clinical efficacy evidence—particularly regarding cerebrovascular conditions—it was withdrawn from the U.S. market and is no longer available for medical use there. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Arlibide, Buphedrin, Dilatol and Vasiten. Its PubChem CID is 5702098.
Nylidrin hydrochloride
| CAS No | 849-55-8 |
|---|---|
| Molecular Formula | C19H26ClNO2 |
| Molecular Weight | 335.9 g/mol |
| Synonyms | 4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nylidrin hydrochloride is a vasodilating β‑adrenergic agonist formerly used to treat peripheral vascular disorders and certain organic mental symptoms in elderly patients.
The listed CAS number is 849-55-8.
The listed molecular formula is C19H26ClNO2.
The listed molecular weight is 335.9 g/mol.
4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol;hydrochloride.
The source lists Arlibide, Buphedrin, Dilatol and Vasiten.